Skip to main content

Teresa Vendrell Bayona

Institutions of which they are part

Genetics Medicine
Vall Hebron Institut de Recerca

Teresa Vendrell Bayona

Institutions of which they are part

Genetics Medicine
Vall Hebron Institut de Recerca

Projects

Implementació de la Medicina Personalitzada basada en la Genòmica en Malalties Minoritàries Neurològiques no Diagnosticades

IP: Alfons Macaya Ruíz
Collaborators: Elena García Arumí, Francina Munell Casadesus, Teresa Vendrell Bayona, Ramon Martí Seves, David Gómez Andrés, Implementació de la Medicina Personalitzada basada en la Genòmica en Malalties Minoritàries Neurològiques no Diagnosticades
Funding agency: Generalitat de Catalunya - Departament de Salut
Funding: 113977.67
Reference: SLT002/16/00174
Duration: 01/01/2017 - 31/12/2019

Investigación del papel de las reorganizaciones genómicas en los Defectos Congénitos del Corazón (DGC) y desarrollo de nuevas herramientas de diagnóstico genético prenatal y postnatal

IP: Alberto Plaja Rustein
Collaborators: Maria Ángeles Sánchez Durán, Teresa Vendrell Bayona, Gemma Giralt García, Asunción Fernández Rodríguez
Funding agency: Instituto de Salud Carlos III
Funding: 109505
Reference: PI09/00632
Duration: 01/01/2010 - 31/12/2013

Genetic basis of Chiari type I malformation

IP: Alfons Macaya Ruíz
Collaborators: Ma Antonia Poca Pastor, Teresa Vendrell Bayona
Funding agency: Fundació La Marató de TV3
Funding: 194125
Reference: MARATV3_062710
Duration: 07/02/2007 - 30/06/2011

Oncologia Molecular i Envelliment

IP: Simon Schwartz Navarro
Collaborators: Alberto Plaja Rustein, Teresa Vendrell Bayona, Manuel Armengol Carrasco, Eloy Espín Basany
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 36600
Reference: 2005SGR 00076
Duration: 01/01/2006 - 31/12/2008

Related news

The results show that, in some patients with mutations in the X chromosome, the healthy gene is inactivated and the mutated gene manifests itself, which favors the onset of the disease.

On January 24, a session was held to explain what these three-dimensional models are and what advantages they have, as well as to review some of their applications in research.

The research has studied the structure and function of proteins related to this degenerative disease and their interaction with SMN2 messenger RNA (mRNA), which is key to the evolution of patients.

Related professionals

Maria del Carmen Llorente Olmedo

Maria del Carmen Llorente Olmedo

Shock, Organ Dysfunction and Resuscitation
Read more
Macias Chimborazo, Valeria

Macias Chimborazo, Valeria

Research technician
Psychiatry, Mental Health and Addictions
Read more
Luis Morales Quinteros

Luis Morales Quinteros

Predoctoral researcher
Shock, Organ Dysfunction and Resuscitation
Read more
Cristina Aguilera Martin

Cristina Aguilera Martin

Main researcher
Clinical Pharmacology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.